BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 10695094)

  • 21. Amoxycillin versus ampicillin in treatment of exacerbations of chronic bronchitis.
    Mackay AD
    Br J Dis Chest; 1980 Oct; 74(4):379-84. PubMed ID: 7011353
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patient stratification in the management of acute bacterial exacerbation of chronic bronchitis: the role of levofloxacin 750 mg.
    Martinez FJ; Grossman RF; Zadeikis N; Fisher AC; Walker K; Ambruzs ME; Tennenberg AM
    Eur Respir J; 2005 Jun; 25(6):1001-10. PubMed ID: 15929954
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Efficacy and tolerability of pristinamycin vs amoxicillin-clavulanic acid combination in the treatment of acute community-acquired pneumonia in hospitalized adults].
    Poirier R; Chardon H; Beraud A; Debieuvre D; Petitprez P; Montestruc F; Lilienthal F; Janus C
    Rev Pneumol Clin; 1997; 53(6):325-31. PubMed ID: 9616826
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gemifloxacin once daily for 7 days compared to amoxicillin/clavulanic acid thrice daily for 10 days for the treatment of community-acquired pneumonia of suspected pneumococcal origin.
    Léophonte P; File T; Feldman C
    Respir Med; 2004 Aug; 98(8):708-20. PubMed ID: 15303634
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Five-day moxifloxacin therapy compared with 7-day co-amoxiclav therapy for the treatment of acute exacerbation of chronic bronchitis.
    Starakis I; Gogos CA; Bassaris H
    Int J Antimicrob Agents; 2004 Feb; 23(2):129-37. PubMed ID: 15013037
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Randomised controlled trial of amoxycillin clavulanate in children with chronic wet cough.
    Marchant J; Masters IB; Champion A; Petsky H; Chang AB
    Thorax; 2012 Aug; 67(8):689-93. PubMed ID: 22628120
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative study of levofloxacin in the treatment of children with community-acquired pneumonia.
    Bradley JS; Arguedas A; Blumer JL; Sáez-Llorens X; Melkote R; Noel GJ
    Pediatr Infect Dis J; 2007 Oct; 26(10):868-78. PubMed ID: 17901791
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of ofloxacin otic solution with oral amoxycillin plus chloramphenicol ear drop in treatment of chronic suppurative otitis media with acute exacerbation.
    Supiyaphun P; Kerekhanjanarong V; Koranasophonepun J; Sastarasadhit V
    J Med Assoc Thai; 2000 Jan; 83(1):61-8. PubMed ID: 10710871
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Three vs. 10 days of amoxycillin-clavulanic acid for type 1 acute exacerbations of chronic obstructive pulmonary disease: a randomised, double-blind study.
    Roede BM; Bresser P; El Moussaoui R; Krouwels FH; van den Berg BT; Hooghiemstra PM; de Borgie CA; Speelman P; Bossuyt PM; Prins JM
    Clin Microbiol Infect; 2007 Mar; 13(3):284-90. PubMed ID: 17391383
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of spiramycin and clarithromycin for community-acquired lower respiratory tract infections.
    Rocha RT; Awad CE; Ali A; Matyas R; Vital AC; Silva CO; Dainesi SM; Salazar MS; Nakatani J
    Int J Clin Pract; 1999 Sep; 53(6):433-6. PubMed ID: 10622070
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of prior effective therapy on the efficacy of daptomycin and ceftriaxone for the treatment of community-acquired pneumonia.
    Pertel PE; Bernardo P; Fogarty C; Matthews P; Northland R; Benvenuto M; Thorne GM; Luperchio SA; Arbeit RD; Alder J
    Clin Infect Dis; 2008 Apr; 46(8):1142-51. PubMed ID: 18444848
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The development of pharmacokinetically enhanced amoxicillin/clavulanate for the management of respiratory tract infections in adults.
    File TM
    Int J Antimicrob Agents; 2007 Dec; 30 Suppl 2():S131-4. PubMed ID: 18029151
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Once-daily, high-dose levofloxacin versus ticarcillin-clavulanate alone or followed by amoxicillin-clavulanate for complicated skin and skin-structure infections: a randomized, open-label trial.
    Graham DR; Talan DA; Nichols RL; Lucasti C; Corrado M; Morgan N; Fowler CL
    Clin Infect Dis; 2002 Aug; 35(4):381-9. PubMed ID: 12145720
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Moxifloxacin monotherapy is effective in hospitalized patients with community-acquired pneumonia: the MOTIV study--a randomized clinical trial.
    Torres A; Garau J; Arvis P; Carlet J; Choudhri S; Kureishi A; Le Berre MA; Lode H; Winter J; Read RC;
    Clin Infect Dis; 2008 May; 46(10):1499-509. PubMed ID: 18419482
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Twice daily dosing of erythromycin acistrate in the treatment of acute bronchitis and pneumonia.
    Wiesner B; Wilen-Rosenqvist G; Lehtonen L
    Arzneimittelforschung; 1993 Sep; 43(9):1014-7. PubMed ID: 8240450
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of ceftibuten once daily and amoxicillin-clavulanate three times daily in the treatment of acute exacerbations of chronic bronchitis.
    McAdoo MA; Rice K; Gordon GR; Sahn SA
    Clin Ther; 1998; 20(1):88-100. PubMed ID: 9522107
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A short (3-day) course of azithromycin tablets versus a 10-day course of amoxycillin-clavulanic acid (co-amoxiclav) in the treatment of adults with lower respiratory tract infections and effects on long-term outcome.
    Hoepelman IM; Möllers MJ; van Schie MH; Greefhorst AP; Schlösser NJ; Sinninghe Damsté EJ; van de Moosdijk CN; Dalinghaus WH; Eland ME; Mol SJ; Rozenberg-Arska M
    Int J Antimicrob Agents; 1997 Jan; 9(3):141-6. PubMed ID: 9552709
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A multi-centre general practice comparison of a fixed-dose combination of pivmecillinam plus pivampicillin with amoxycillin in respiratory tract infections.
    Shenderey K; Marsh BT; Talbot DJ
    Pharmatherapeutica; 1985; 4(5):300-5. PubMed ID: 4070323
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical effectiveness of a combination of bromhexine and amoxicillin in lower respiratory tract infection. A randomized controlled trial.
    Roa CC; Dantes RB
    Arzneimittelforschung; 1995 Mar; 45(3):267-72. PubMed ID: 7741782
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Oral and parenteral amoxicillin in the treatment of pneumonia and acute bronchitis].
    Ekoule D
    Pharmatherapeutica; 1989; 5(6):387-91. PubMed ID: 2594821
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.